The FDA Could Help Address Financial Toxicity During the Approval Process

Sep 21, 2019 – Cancer is among the costliest medical conditions to treat in the United States, causing many patients to experience “financial toxicity.” This term is often used to describe how out-of-pocket costs can cause financial distress to patients. One of the major challenges with financial toxicity as it relates to any disease state, but especially to oncology, is the high cost of medication. Compared with other illnesses, cancer drug costs can be astronomical. For … (leggi tutto)